EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk‐Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real‐World Study

Chun Ye iD, Yi Liu, Huiru Huang, Ruizhe Chen, Ying Li, Xiaofei Zhang, Yunfeng Fu iD, Liang Feng, Xiao Li

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Chun Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Genotype, Triage, Papillomaviridae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Key Research and Development Program of Zhejiang Province (2023C03169)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the immediate risk of (pre)cancer for cytology low‐grade squamous intraepithelial lesion (LSIL) women infected with or without specific HPV genotype and develop a risk‐based management strategy. A total of 4567 LSIL women with extended HPV genotyping and colposcopy results were enrolled according to the inclusive and exclusive criteria. The distribution and immediate cervical intraepithelial neoplasia grade 2 or worse and 3+ or worse (CIN2+/3+) risks of specific HPV genotypes were assessed using Minimum Estimate, Any Type Estimate, and Hierarchical Attribution Estimate. A risk‐based strategy was further established and evaluated. CIN2+/3+ were 729/328 cases, including 691/317 in 3398 HPV‐positive and 38/11 in 1169 HPV‐negative women. HPV16, 52, 58, and 18 were the most prevalent genotypes in both HPV‐positive and CIN2+/3+ cases. HPV16, 73, and 33 carried the highest immediate CIN2+/3+ risk. A risk‐based strategy was established, which suggested Group A (HPV 16, 33, 45, 31, 18, 58, 52, 35, 73, 82; with immediate CIN3+ risk of 4.08%–22.12%) for immediate colposcopy, Group B (HPV 59, 66, 56, 53) for 6‐month follow‐up or p16/Ki‐67 dual stain or DNA methylation triage, while Group C (HPV 51, 68, 39, 26) for 1‐year HPV repeat testing. Compared with conventional strategy, this new strategy showed significantly higher specificity (CIN2+: 52.16% vs. 29.47%, χ 2 = 409.136, p < 0.001; CIN3+: 48.45% vs. 27.32%, χ 2 = 402.395, p < 0.001) but similar sensitivity, which could reduce immediate colposcopy referrals by 19.82%. A risk‐based triage strategy for LSIL women with extended HPV genotyping could effectively reduce unnecessary colposcopies and maintain high efficacy for CIN2+/3+ detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsGenotypeTriagePapillomaviridaeUterine Cervical NeoplasmsUterine Cervical DysplasiaSquamous Intraepithelial LesionsHumansFemaleAdultMiddle AgedColposcopyYoung AdultGenotyping TechniquesEarly Detection of CancerRisk AssessmentAged

Stichwörter der Autor:innen

cervical intraepithelial neoplasiaextended HPV genotypinghuman papillomaviruslow‐grade squamous intraepithelial lesionrisk‐based triage strategy

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Medical Centre for Cervical Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Gynecology and Obstetrics, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Department of Pathology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Provincial Center for Disease Control, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, China.

ORCID-Profile: Chun Ye, Yunfeng Fu

Förderung

  • This study was supported by the Key Research and Development Program of Zhejiang Province (2023C03169).

Zitieren

APA

Ye, C., Liu, Y., Huang, H., Chen, R., Li, Y., Zhang, X., Fu, Y., Feng, L., & Li, X. (2025). Risk‐Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real‐World Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70404

Vancouver

Ye C, Liu Y, Huang H, Chen R, Li Y, Zhang X, et al. Risk‐Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real‐World Study. Journal of Medical Virology. 2025. doi:10.1002/jmv.70404

BibTeX
@article{Ye2025,
  author = {Ye, Chun and Liu, Yi and Huang, Huiru and Chen, Ruizhe and Li, Ying and Zhang, Xiaofei and Fu, Yunfeng and Feng, Liang and Li, Xiao},
  title = {Risk‐Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real‐World Study},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70404}
}
Kostenlos starten →